Drogué, abusé, filmé Pourquoi de nombreuses victimes ne se rendent compte que tardivement de ce qui s'est passé

An ex-member of the Swiss People's Party (SVP) has been accused of repeatedly sexually assaulting women who were rendered unconscious with drugs, according to recent reports. The allegations emerged after investigative journalism by Tages-Anzeiger revealed ongoing police inquiries into the case. The suspect maintains his innocence, though authorities have taken action against two individuals linked to the incidents. This case highlights the complex challenges faced by victims of such crimes, particularly in identifying and reporting abuse when memory is compromised. The alleged perpetrator, a former cantonal councilor from the canton of Aargau, is reportedly accused of using sedatives to incapacitate multiple women before committing sexual assault and recording the acts. These accusations came to light following a media investigation that exposed the ongoing legal proceedings. While the defendant is presumed innocent under Swiss law, prosecutors have not yet filed formal charges. The situation underscores the difficulties in prosecuting cases involving drug-induced unconsciousness, where victims often lack recollection of the events. Victims of similar offenses frequently struggle to recognize their experiences due to the effects of substances like GHB, which can cause temporary amnesia. According to Brigitte Kämpf, a specialist at the “Frauenberatung sexuelle Gewalt” (Women’s Counseling Against Sexual Violence) organization, many survivors wake up in unfamiliar locations, disoriented and unable to recall what transpired. She explains that while some victims may notice physical signs, such as bruises, discomfort, or unexplained injuries, others remain unaware of the nature of the attack. There is no definitive marker to confirm the use of sedatives, making it challenging for both victims and investigators to establish clear evidence. When victims do seek help, they often turn to specialized support services. Kämpf notes that early intervention is crucial. Within 72 hours of an incident, professionals recommend forensic nursing care to collect biological samples, including sperm traces and DNA. GHB, one of the common substances used in these attacks, can be detected in blood for four to eight hours and in urine for eight to twelve hours. However, this window is often missed because victims may be unconscious during the critical period. As a result, forensic evidence becomes harder to obtain, complicating legal proceedings. For victims considering whether to file a formal complaint, Kämpf emphasizes that the decision depends on individual circumstances. Some seek justice through prosecution, hoping for conviction or compensation, while others aim to set boundaries by reporting the crime. Even if charges are not pursued, the process itself can provide closure. Nevertheless, the emotional toll of pursuing legal action can be profound, especially when outcomes fall short of expectations. In some cases, victims report feeling retraumatized by the experience. Research efforts are underway to improve detection methods. Scientists have identified a protein produced in response to artificially administered GHB, potentially leading to more reliable testing procedures. However, these developments are still in progress, and practical implementation may take time. Meanwhile, awareness of such crimes appears to be increasing, with media coverage drawing attention to previously overlooked issues. Kämpf suggests that public discourse around these matters is evolving, possibly encouraging more survivors to come forward and seek assistance.